Skip to content
SignaBlok
  • News & Publications
    • News
    • Publications
  • Contact Us
  • About Us
    • History
    • Patents
  • Technology
    • Signaling Chain HOmoOLigomerization (“SCHOOL”) Platform Basics
    • Macrophage Modulation
    • Macrophage Imaging
  • Pipeline
  • Therapeutic Areas
    • Cancer
    • Autoimmune Diseases
    • Retinopathy
    • Atherosclerosis
    • Sepsis/ARDS & COVID
    • Other Inflammatory Diseases
  • Partners & Collaborators
Menu
Understanding Nature. Improving Life
Type and press enter to search

Contact Us

SignaBlok > Contact Us
SignaBlok > Contact Us

SignaBlok, Inc.
P.O. Box 4064
Shrewsbury, MA 01545
USA
info@signablok.com

    Print

    • Contact Us

    “SCHOOL”: Signaling Chain HOmoOLigomerization

    This discovery opens new avenues for drug development with applications in many serious diseases.

    Read More

    Publications

    Check our latest News and Publications

    Read More

    SignaBlok, Inc.
    P.O. Box 4064
    Shrewsbury, MA 01545
    USA

    info@signablok.com

    • About Us
    • History
    • Patents
    • News & Publications
    • News
    • Publications
    • Technology
    • Signaling Chain HOmoOLigomerization (“SCHOOL”) Platform Basics
    • Macrophage Modulation
    • Macrophage Imaging
    • Signablok
    • Pipeline
    • Partners & Collaborators
    • Contact Us
    • Sitemap
    • Therapeutic Areas
    • Cancer
    • Autoimmune Diseases
    • Retinopathy
    • Atherosclerosis
    • Sepsis/ARDS & COVID
    • Other Inflammatory Diseases
    © Copyright . All Right Reserved
    Website by Axxiem
    Scroll to top
    close ×
    Full View Full View